What does the Dexcom G6 receiver do?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What the Dexcom G6 Receiver Does

The Dexcom G6 receiver is a handheld device that wirelessly receives and displays continuous glucose data from the G6 sensor, showing current glucose levels, trend arrows indicating direction and velocity of glucose changes, and historical glucose patterns—functioning as an alternative to using a smartphone for viewing CGM data. 1, 2

Core Functions

The receiver serves as a real-time continuous glucose monitoring (rtCGM) display device that automatically receives transmitted data from the sensor without requiring manual scanning. Specifically, it:

  • Displays current glucose readings in numerical format continuously
  • Shows glucose trend arrows indicating the direction and velocity of changing blood glucose levels
  • Provides graphical glucose patterns over time
  • Delivers active alarms and alerts for hypoglycemia and hyperglycemia (critical for those with impaired hypoglycemia awareness or frequent severe hypoglycemia) 1
  • Stores historical data that can be downloaded for retrospective analysis 1

Technical Specifications

The receiver operates within approximately 6 meters (20 feet) of the sensor via Bluetooth transmission 2. This allows for remote monitoring capabilities—the receiver doesn't need to be in direct contact with the sensor like intermittently scanned CGM (isCGM) systems that require "swiping" 1.

Clinical Context

The Dexcom G6 is a factory-calibrated rtCGM system that does not require fingerstick calibrations (unlike earlier CGM generations) 2. The receiver provides nonadjunctive glucose monitoring, meaning treatment decisions including insulin dosing can be made based on the receiver's displayed values without confirmatory fingerstick blood glucose measurements in most situations 3.

Receiver vs. Smartphone Option

While the receiver is the dedicated display device, the Dexcom G6 system also allows smartphone use as an alternative through the Dexcom G6 app (available for Android or iOS) 2. The receiver remains an option for patients who:

  • Prefer a dedicated medical device
  • Don't have compatible smartphones
  • Want a backup display option
  • Need device redundancy for safety

Important Caveats

  • The receiver displays interstitial glucose (not blood glucose), which typically lags behind blood glucose by several minutes 2
  • Confirmatory fingerstick testing may still be needed when symptoms don't match sensor readings or during sensor malfunction 1
  • The receiver must remain within range of the sensor for continuous data transmission 2

References

1
Guideline

american association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2021

2
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

3
Guideline

american association of clinical endocrinologists and american college of endocrinology 2018 position statement on integration of insulin pumps and continuous glucose monitoring in patients with diabetes mellitus.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2018

Related Questions

For a 90‑day supply, how many Dexcom continuous glucose monitoring sensors, transmitters, and receivers should be ordered?
What is the appropriate days‑supply to enter for the Dexcom G7 receiver kit?
How do I prescribe a Dexcom G6 continuous glucose monitor for a patient with unstable type 1 diabetes and life‑threatening hypoglycemia who has Medicaid insurance in North Carolina?
Is a smartphone required to use the Dexcom G7 or Dexcom G6 continuous glucose monitor in a patient without a phone?
How often should the Dexcom (continuous glucose monitoring system) G6 sensor be replaced in patients with diabetes?
What is the appropriate brand name (with generic name) for single‑inhaler triple therapy and what is the comprehensive management plan?
Is Trilogy 200 (budesonide 200 µg / glycopyrrolate 50 µg / formoterol 12 µg) appropriate for a patient with moderate‑to‑severe chronic obstructive pulmonary disease, CAT score ≥10, mMRC grade ≥2, post‑bronchodilator FEV1 <80 % predicted, and a history of ≥2 moderate or ≥1 severe exacerbation in the past year, and what additional therapies or measures should be added to the management plan?
At what platelet count should tinzaparin (Fraxiparine) prophylaxis for deep vein thrombosis be stopped?
Is gabapentin (Neurontin) useful in the management of acute alcohol withdrawal syndrome?
For a patient with moderate-to-severe COPD (CAT score ≥10, mMRC grade ≥2, FEV1 <80% predicted, and ≥2 moderate or ≥1 severe exacerbations in the past year), is a regimen of budesonide 200 µg/glycopyrrolate 50 µg/formoterol 12 µg (Trilogy 200) twice daily, albuterol sulfate (SFA) as a rescue inhaler, and oral prednisone 10 mg daily adequate, or are additional therapies needed?
What is the standard multidisciplinary management for a newly diagnosed breast carcinoma, including surgical approach and options for immediate or delayed plastic reconstruction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.